Biosceptre International Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Biosceptre International Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10659
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Biosceptre International Ltd (Biosceptre) is a biotechnology company that develops antibody technologies for applications in the diagnosis and treatment of cancer. The company develops imaging technologies to detect and monitor cancer. Its diagnostic products are used for the detection of various cancer tissues, and treatment of various cancers in humans and other mammals. Biosceptre offers clinical product development programs such as polyclonal antibody, domain antibodies and topical formulation to treat basal cell carcinoma and other skin cancers. The company also develops diagnostics and a line of veterinary therapeutic products. It has operations in the UK, Australia, and the US. Biosceptre is headquartered in Cambridge, the UK.

Biosceptre International Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biosceptre International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biosceptre International Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Biosceptre International Raises USD10.7 Million in Series A Financing 11
Biosceptre International Raises USD0.2 Million in Venture Financing 12
Biosceptre Raises Funds through Venture Financing 13
Biosceptre Raises USD0.7 Million in Venture Financing 14
Biosceptre International Raises USD4.7 Million in Venture Financing 15
Partnerships 16
AIBN Enters Into Co-Development Agreement With Biosceptre For Cancer Antibodies 16
Biosceptre International Ltd – Key Competitors 17
Biosceptre International Ltd – Key Employees 18
Biosceptre International Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biosceptre International Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biosceptre International Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Biosceptre International Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biosceptre International Raises USD10.7 Million in Series A Financing 11
Biosceptre International Raises USD0.2 Million in Venture Financing 12
Biosceptre Raises Funds through Venture Financing 13
Biosceptre Raises USD0.7 Million in Venture Financing 14
Biosceptre International Raises USD4.7 Million in Venture Financing 15
AIBN Enters Into Co-Development Agreement With Biosceptre For Cancer Antibodies 16
Biosceptre International Ltd, Key Competitors 17
Biosceptre International Ltd, Key Employees 18
Biosceptre International Ltd, Subsidiaries 19

List of Figures
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Biosceptre International Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Biosceptre International Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Biosceptre International Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dubai Electricity and Water Authority:企業の戦略的SWOT分析
    Dubai Electricity and Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Aoyama Trading Co., Ltd.:企業の戦略・SWOT・財務分析
    Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aoyama Trading Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Mead Johnson Nutrition Company:企業の戦略・SWOT・財務情報
    Mead Johnson Nutrition Company - Strategy, SWOT and Corporate Finance Report Summary Mead Johnson Nutrition Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Connected Energy:企業の戦略的SWOT分析
    Connected Energy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Chiltern International Inc-製薬・医療分野:企業M&A・提携分析
    Summary Chiltern International Inc (Chiltern) is a contract research organization that provides clinical trial development services. It conducts clinical trials for medical devices, drugs, and diagnostics across all stages of development. The company offer wide range of services including clinical d …
  • HD Biosciences (China) Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary HD Biosciences (China) Co Ltd (HDB), a subsidiary of WuXi AppTec (Shanghai) Co Ltd, is a contract research organization that offers drug discovery research services. The organization develops and provides products such as mycoplasma detection kit and wash free calcium assay kit, among others …
  • Dare Bioscience Inc (DARE):医療機器:M&Aディール及び事業提携情報
    Summary Dare Bioscience Inc (Dare Bioscience), formerly Cerulean Pharma Inc, is a clinical stage biopharmaceutical company that develops products for women’s reproductive health. The company, through its dynamic tumor targeting platform, creates nanoparticle drug conjugates to attack tumor cells, re …
  • Japan Foods Co Ltd:企業の戦略・SWOT・財務情報
    Japan Foods Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Foods Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Turk Hava Yollari Anonim Ortakligi:企業の戦略・SWOT・財務情報
    Turk Hava Yollari Anonim Ortakligi - Strategy, SWOT and Corporate Finance Report Summary Turk Hava Yollari Anonim Ortakligi - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • ViacomCBS Inc (VIAC):企業の財務・戦略的SWOT分析
    ViacomCBS Inc (VIAC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Enzymotec Ltd:企業の戦略・SWOT・財務情報
    Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report Summary Enzymotec Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Aragen Bioscience Inc-製薬・医療分野:企業M&A・提携分析
    Summary Aragen Bioscience Inc (Aragen), a subsidiary of GVK Biosciences Inc is a contract research organisation that provides preclinical contract research and development services. The company provides recombinant cell line and hybridoma development, cell culture and protein purification process de …
  • Sparton Resources Inc (SRI):企業の財務・戦略的SWOT分析
    Summary Sparton Resources Inc (Sparton Resources) is a diversified company that acquires and develops oil and gas properties in North America and China. The company’s products portfolio includes vanadium, natural gas, crude oil, gold, and vanadium flow batteries, among others. Its energy projects co …
  • Luna Innovations Inc (LUNA)-医療機器分野:企業M&A・提携分析
    Summary Luna Innovations Inc (Luna) is a optical technology development company that research, develops and commercializes speed optics and fiber optic test products. The company’s products include fiber optic sensing products, fiber optic test and measurement products, high speed optical products, …
  • Faron Pharmaceuticals Oy (FARN):企業の財務・戦略的SWOT分析
    Summary Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that develops treatments for unmet medical needs. The company is developing pipeline products with a focus on vascular damage, acute organ traumas and cancer immunotherapy. It offers Clevegen, a humanized Clever-1 …
  • Banco Bilbao Vizcaya Argentaria SA:戦略・SWOT・企業財務分析
    Banco Bilbao Vizcaya Argentaria SA - Strategy, SWOT and Corporate Finance Report Summary Banco Bilbao Vizcaya Argentaria SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Royal Mail plc (RMG):企業の財務・戦略的SWOT分析
    Royal Mail plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Rosneft Oil Co (ROSN):電力:M&Aディール及び事業提携情報
    Summary Rosneft Oil Company (Rosneft) is a vertically integrated oil and gas company that explores for, develops and produces crude oil, natural gas and condensates; and refines, markets and distributes petroleum products and petrochemicals. It has exploration assets across Western Siberia, Eastern …
  • The Scripps Research Institute-医療機器分野:企業M&A・提携分析
    Summary The Scripps Research Institute (TSRI) is a research and educational organization that conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune diseases, chemistry, molecular and cellular biology, virology and synthetic vaccine development. The institut …
  • KEB Hana Bank:企業の戦略・SWOT・財務情報
    KEB Hana Bank - Strategy, SWOT and Corporate Finance Report Summary KEB Hana Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆